跳到主要导航 跳到搜索 跳到主要内容

Lack of nucleophosmin mutation in patients with myelodysplastic syndrome and acute myeloid leukemia with chromosome 5 abnormalities

  • Masayuki Shiseki*
  • , Yukiko Kitagawa
  • , Yan Hua Wang
  • , Kentaro Yoshinaga
  • , Toshiaki Kondo
  • , Hanae Kuroiwa
  • , Michiko Okada
  • , Naoki Mori
  • , Toshiko Motoji
  • *此作品的通讯作者
  • Tokyo Women's Medical University
  • Shiseikai Dai-Ni Hospital

科研成果: 期刊稿件 › 文章 › 同行评审

摘要

Nucleophosmin (NPM1) gene exon 12 mutations are frequently present in patients with acute myeloid leukemia (AML) with normal karyotype. The NPM1 gene is located on chromosome 5q35, which is often affected in myeloid malignancies including myelodysplastic syndrome (MDS). This suggests that the NPM1 gene is a one of the target genes affected by chromosome 5 abnormalities and play a role in the development of MDS. It has not been clarified whether MPM1 mutations are present in patients with MDS and AML with chromosome 5 abnormalities. Therefore, we carried out a mutational analysis on the NPM1 gene exon 12. NPM1 mutations were not detected in the 28 patients with MDS and AML with chromosome 5 abnormalities.

源语言英语
页(从-至)2141-2144
页数4
期刊Leukemia and Lymphoma
卷48
期11
DOI
出版状态已出版 - 11月 2007
已对外发布是

联合国可持续发展目标

此成果有助于实现下列可持续发展目标:

  1. 可持续发展目标 3 - 良好健康与福祉
    可持续发展目标 3 良好健康与福祉

学术指纹

探究 'Lack of nucleophosmin mutation in patients with myelodysplastic syndrome and acute myeloid leukemia with chromosome 5 abnormalities' 的科研主题。它们共同构成独一无二的学术指纹。

引用此